Li Lei, Xu Yawei, Yang Wuping, Zhang Kenan, Zhang Zedan, Zhou Jingcheng, Gong Yanqing, Gong Kan
Department of Urology, Peking University First Hospital, Beijing, China.
Institution of Urology, Peking University, Beijing, China.
Transl Androl Urol. 2023 Jul 31;12(7):1167-1183. doi: 10.21037/tau-23-346. Epub 2023 Jul 24.
Renal cell carcinoma (RCC) is a common and aggressive tumor. A newly discovered form of programmed cell death, ferroptosis, plays an important role in tumor development and progression. However, a clear prognostic correlation between Ferroptosis-related genes (FRGs) and RCC has not yet been established. In this study, prognostic markers associated with FRGs were investigated to improve the therapeutic, diagnostic, and preventive strategies available to patients with renal cancer.
The present study analyzed the predictive value of 23 FRGs in RCC through bioinformatics techniques, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) tools, Kaplan-Meier survival analysis, Cox regression modeling, tumor mutational burden (TMB), CIBERSORT, and half maximal inhibitory concentration (IC) difference analysis.
We screened FRGs by differentially expressed genes (DEGs) and overall survival (OS). Four candidate genes were obtained by hybridization. Then, we constructed a two-gene prognostic signature ( and ) via univariate Cox regression and multivariate stepwise Cox regression, which classified RCC patients into high- and low-risk groups, and patients in the high-risk group were found to have worse OS and progression-free survival (PFS). We also found that patients with higher TNM stage, T stage, and M stage had higher risk scores than those with lower TNM stage, T stage, and M stage (P<0.05). Males had higher risk scores than females. This signature was identified as an independent prognostic indicator for RCC. These results were validated in both the test cohort and the entire cohort. In addition, we also constructed a nomogram that predicted the OS in RCC patients, the consistency index (C-index) of the nomogram was 0.731 [95% confidence interval (CI): 0.672-0.790], the areas under the receiver operating characteristic (ROC) curves (AUCs) were 0.728, 0.704, and 0.898 at 1-, 3-, and 5-year, respectively, which shows that nomogram has good prediction ability. and we also analyzed the immune status and drug sensitivity between the high- and low-risk groups.
We constructed a prognostic model associated with ferroptosis, which may provide clinicians with a reliable predictive assessment tool and offer new perspectives for the future clinical management of RCC.
肾细胞癌(RCC)是一种常见的侵袭性肿瘤。一种新发现的程序性细胞死亡形式——铁死亡,在肿瘤的发生发展中起重要作用。然而,铁死亡相关基因(FRGs)与RCC之间明确的预后相关性尚未确立。在本研究中,我们研究了与FRGs相关的预后标志物,以改善肾癌患者的治疗、诊断和预防策略。
本研究通过生物信息学技术分析了23个FRGs在RCC中的预测价值,包括基因本体论(GO)和京都基因与基因组百科全书(KEGG)工具、Kaplan-Meier生存分析、Cox回归建模、肿瘤突变负荷(TMB)、CIBERSORT和半数最大抑制浓度(IC)差异分析。
我们通过差异表达基因(DEGs)和总生存期(OS)筛选FRGs。通过杂交获得了四个候选基因。然后,我们通过单变量Cox回归和多变量逐步Cox回归构建了一个双基因预后特征( 和 ),将RCC患者分为高风险组和低风险组,发现高风险组患者的OS和无进展生存期(PFS)较差。我们还发现,TNM分期、T分期和M分期较高的患者的风险评分高于TNM分期、T分期和M分期较低的患者(P<0.05)。男性的风险评分高于女性。该特征被确定为RCC的独立预后指标。这些结果在测试队列和整个队列中均得到验证。此外,我们还构建了一个预测RCC患者OS的列线图,列线图的一致性指数(C-index)为0.731 [95%置信区间(CI):0.672 - 0.790],在1年、3年和5年时,受试者操作特征(ROC)曲线下面积(AUC)分别为0.728、0.704和0.898,表明列线图具有良好的预测能力。并且我们还分析了高风险组和低风险组之间的免疫状态和药物敏感性。
我们构建了一个与铁死亡相关的预后模型,这可能为临床医生提供一个可靠的预测评估工具,并为RCC未来的临床管理提供新的视角。